Evidence map›Paper›PMID 42783149›Full record

ReviewBiosensors2026

Nanocarbon as a Quantum Material for Biointerfaces and Magnetic Platforms in Theranostic Biomedicine in Oncology: A Critical Review.

Priscila M Galdino, Barbara R Geraldino, Nilséia A Barbosa, Fernando M Araújo-Moreira

Abstract readReview
In one paragraph

Review in Biosensors, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Priscila M GaldinoNuclear Engineering Department, Instituto Militar de Engenharia (IME), Praça General Tibúrcio, 80, Urca, Rio de Janeiro 22290-270, Brazil.ORCID 0009-0006-2065-5081
Barbara R GeraldinoNuclear Engineering Department, Instituto Militar de Engenharia (IME), Praça General Tibúrcio, 80, Urca, Rio de Janeiro 22290-270, Brazil.ORCID 0000-0002-7061-1574
Nilséia A BarbosaNuclear Engineering Department, Instituto Militar de Engenharia (IME), Praça General Tibúrcio, 80, Urca, Rio de Janeiro 22290-270, Brazil.ORCID 0009-0006-9455-7441
Fernando M Araújo-MoreiraNuclear Engineering Department, Instituto Militar de Engenharia (IME), Praça General Tibúrcio, 80, Urca, Rio de Janeiro 22290-270, Brazil.ORCID 0000-0002-5423-0405

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nanostructured carbon materials are low-dimensional systems relevant to oncology biosensing, with their utility arising from an electronic structure coupled to defect and edge states, a charge-transfer behavior and optical response that report molecular binding, an interfacial chemistry governing contact with the analyte, and, in selected cases, magnetic properties enabling manipulation and readout. In functional terms, these behaviors trace to specific quantum-relevant features-quantum confinement, edge and defect states, and the resulting size-dependent optical and charge-transfer responses-rather than to a generic quantum-material designation. This critical review treats nanocarbons as engineered biointerfaces whose performance is set by how the carbon surface behaves in biological fluid, how recognition chemistry is anchored, and how the binding event is transduced, with magnetic responsiveness, stability, reproducibility, and fabrication control as decisive constraints. The analysis separates three material classes-non-magnetic nanocarbon sensors, hybrid carbon-magnetic systems, and defect-associated or potentially metal-free magnetic carbons-while grading evidence as direct, adjacent, comparator-derived, or prospective. Directly, graphene, carbon nanotubes, carbon dots, graphene quantum dots, and magnetic carbon hybrids serve in electrochemical, optical and fluorescent, field-effect, and magnetic-assisted formats. Clinical translation, however, remains constrained by biofouling, protein-corona formation, matrix interference, unstable functionalization, batch variability, incomplete standardization, and scarce validation in real samples and patient cohorts. Metal-free or defect-associated magnetic carbons therefore warrant caution, remaining prospective platforms until the preservation of magnetic response, reproducible functionalization, matrix compatibility, safety, and measurable analytical advantage are directly demonstrated.

Indexed as

Biosensing TechniquesMedical OncologyTheranostic NanomedicineGraphiteHumansMagneticsNanotubes, CarbonQuantum DotsGraphiteNanotubes, Carbonanalytical validationbiointerfacescarbon dotscarbon nanotubesdrug deliverygraphenemagnetic-assisted biosensingmagnetic carbonnanocarbononcology biosensingtranslational nanomedicine

Identifiers

PMID42783149
PMCPMC13604922

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.